Terms: = Testicular cancer AND AFP, AFPD, FETA, HPAFP AND Treatment
256 results:
1. testicular cancer: new developments, molecular pathology, and current research keynote.
Lopez-Beltran A
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):204-207. PubMed ID: 37975918
[TBL] [Abstract] [Full Text] [Related]
2. Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience.
Saliyeva S; Boranbayeva R; Bulegenova M; Beloussov V
Pediatr Hematol Oncol; 2024; 41(2):121-134. PubMed ID: 37898912
[TBL] [Abstract] [Full Text] [Related]
3. [Extragonadal germ cell tumor: A case report and review of the literature].
Li P; Wu D; Xu XF; Fu D; Jia RP; Ge JP
Zhonghua Nan Ke Xue; 2022 Nov; 28(11):1026-1030. PubMed ID: 37846120
[TBL] [Abstract] [Full Text] [Related]
4. Retroperitoneal lymph node dissection for testicular cancer is a demanding procedure: detailed real-life data of complications and additional surgical procedures in 295 cases.
Latarius S; Leike S; Erb H; Putz J; Borkowetz A; Thomas C; Baunacke M
World J Urol; 2023 Sep; 41(9):2397-2404. PubMed ID: 37490059
[TBL] [Abstract] [Full Text] [Related]
5. Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
Majewski M; Paffenholz P; Ruf C; Che Y; Seidel C; Heinzelbecker J; Schmelz HU; Matthies C; Albers P; Bokemeyer C; Heidenreich A; Pichler M; Nestler T;
Cancer Med; 2023 Aug; 12(16):16829-16836. PubMed ID: 37392170
[TBL] [Abstract] [Full Text] [Related]
6. Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-only.
Richardson NH; Althouse SK; Ashkar R; Cary C; Masterson T; Foster RS; Einhorn LH; Adra N
Clin Genitourin Cancer; 2023 Aug; 21(4):467-474. PubMed ID: 37088659
[TBL] [Abstract] [Full Text] [Related]
7. Εmerging Biomarkers in the Diagnosis and treatment of testicular Tumors.
Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
[TBL] [Abstract] [Full Text] [Related]
8. French AFU cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
[TBL] [Abstract] [Full Text] [Related]
9. [testicular tumours from a clinical point of view : What urologists and oncologists need to know from the pathologist about testicular cancer].
Oing C; Fankhauser CD
Pathologie (Heidelb); 2022 Nov; 43(6):434-440. PubMed ID: 36156132
[TBL] [Abstract] [Full Text] [Related]
10. [Tumor Lysis Syndrome in a Patient with Germ Cell Tumor : A Case Report].
Koterazawa S; Masui K; Hama Y; Takahashi Y; Sawada A; Akamatsu S; Kobayashi T
Hinyokika Kiyo; 2022 Jun; 68(6):201-205. PubMed ID: 35850510
[TBL] [Abstract] [Full Text] [Related]
11. [Biomarkers in testicular cancer.].
Mayor-de-Castro J; Aragón-Chamizo J; Caño-Velasco J; Hernández-Fernández C
Arch Esp Urol; 2022 Mar; 75(2):113-117. PubMed ID: 35332880
[TBL] [Abstract] [Full Text] [Related]
12. A 10-year retrospective single-center study of alpha-fetoprotein and beta-human chorionic gonadotropin in Romanian children with (para)gonadal tumors and cysts.
Ataikiru UO; Iacob ER; Miron I; Popoiu CM; Boia ES
J Pediatr Endocrinol Metab; 2022 Mar; 35(3):363-371. PubMed ID: 34968016
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical analysis of testicular rhabdomyosarcoma].
Ye JF; Zhao L; Wang GL; Hong K; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1178-1182. PubMed ID: 34916701
[TBL] [Abstract] [Full Text] [Related]
14. Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer.
Brandt MP; Ruf C; Dieckmann KP; Syring I; Ruckes C; Nestler T; Schmelz HU; Dotzauer R; Hiester A; Albers P; Nettersheim D; Bolenz C; Loosen SH; Heidenreich A; Pfister D; Haferkamp A; Zengerling F; Paffenholz P;
World J Urol; 2022 Feb; 40(2):327-334. PubMed ID: 34854948
[TBL] [Abstract] [Full Text] [Related]
15. Successful treatment of radiotherapy and apatinib in patient with mediastinal mixed non-seminomatous germ cell tumor: A case report.
Ren C; Zhao J; Kang L; Di Y; Qiu G; Wang Q
Medicine (Baltimore); 2021 Oct; 100(43):e27617. PubMed ID: 34713845
[TBL] [Abstract] [Full Text] [Related]
16. Outcome of pediatric germ cell tumor with comparison of carboplatin and cisplatin based regimens: A 10-year analysis.
Jain R; Menon P; Bansal D; Kakkar N; Radhika S; Rao KLN; Trehan A
Pediatr Hematol Oncol; 2022 Apr; 39(3):267-277. PubMed ID: 34665989
[TBL] [Abstract] [Full Text] [Related]
17. Late relapsing germ cell tumors with elevated tumor markers.
Che Y; Lusch A; Winter C; Große Siemer R; Buddensieck C; Albers P; Hiester A
World J Urol; 2022 Feb; 40(2):363-371. PubMed ID: 34518930
[TBL] [Abstract] [Full Text] [Related]
18. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein.
Fero KE; Lec PM; Sharma V; Lenis AT; Low J; Litwin MS; Leapman MS; Chamie K
Urology; 2021 Nov; 157():188-196. PubMed ID: 34389428
[TBL] [Abstract] [Full Text] [Related]
19. Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long-term treatment-related toxicities-Results of the French TGM95 study.
Pavone R; Pacquement H; Pasquet M; Sudour-Bonnange H; Hameury F; Sarnacki S; Chastagner P; Faure-Conter C; Poirée M; Taque S; Patte C; Fresneau B
Int J Cancer; 2021 Nov; 149(9):1705-1712. PubMed ID: 34146403
[TBL] [Abstract] [Full Text] [Related]
20. Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.
Ashkar R; Feldman DR; Adra N; Zaid MA; Funt SA; Althouse SK; Perkins SM; Snow CI; Lazzara KM; Sego LM; Quinn DI; Hanna NH; Einhorn LH; Albany C
Invest New Drugs; 2021 Dec; 39(6):1656-1663. PubMed ID: 34031784
[TBL] [Abstract] [Full Text] [Related]
[Next]
